Skip to main content
Premium Trial:

Request an Annual Quote

Agilent to Use Caliper LabChips for Clinical Diagnostic Apps

NEW YORK, July 12 (GenomeWeb News) - Caliper Life Sciences has granted Agilent Technologies a non-exclusive license to use a "majority" of Caliper's microfluidics patent estate to develop clinical diagnostic applications on several Agilent instrument platforms, the companies said today.

 

Specifically, Agilent will incorporate the LabChip microfluidics technology into its 2100 Bioanalyzer, 5100 Automated Lab-on-a-Chip, and future instrument platforms.

 

Separately, the companies said that Agilent will use Caliper as its exclusive supplier of planar LabChip products for the 2100 Bioanalyzer and future products for the next five years.

 

Under the terms of the agreement, Agilent will pay an upfront undisclosed licensing fee to Caliper, as well as royalties on future sales of diagnostic LabChip products. Additional financial terms of the agreement were not disclosed.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.